Nick Smith | VP of Corporate Development & IR |
Norbert Riedel | CEO |
Ashish Khanna | CFO & CBO |
Andy Kidd | President & COO |
Kathryn King | SVP of Clinical Development |
Harald Murck | VP of Medical & Pharmacovigilance |
Myles Minter | William Blair |
Charles Duncan | Cantor Fitzgerald |
Laura Chico | Wedbush Securities |
Marc Goodman | SVB Leerink |
Ritu Baral | Cowen |
Gary Nachman | BMO Capital Markets |
Good afternoon, and welcome to the Aptinyx First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open up the call for your questions. Please be advised that the call is being recorded at the Company's request. At this time, I would like to turn the call over to Nick Smith, Vice President of Corporate Development and Investor Relations at Aptinyx.